SEC Form 4 · accession 0001209191-17-059188
Pediatrix Medical Group, Inc. · MD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cesar L Alvarez
Director
Period of report
Nov 1, 2017
Accepted (ET)
Nov 3, 2017 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000893949
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 1, 2017 | M | 10,668 | $32.325 | A | 44,215 | D | |
| Common StockF1 | Nov 3, 2017 | S | 10,668 | $42.5923 | D | 33,547 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $32.325 | Nov 1, 2017 | M | 10,668 | D | Nov 1, 2010 | Nov 1, 2017 | Common Stock | 10,668 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in twenty-nine (29) separate transactions with prices ranging from $42.35 to $42.81 for an average weighted sales price of $42.5923. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.